BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11788096)

  • 1. Prevalence of CTLA-4 polymorphism A49G in Ashkenazi Jews.
    Mack R; Chowdary D; Samaan P; Podolak I; Dermody J
    Genet Test; 2001; 5(3):269-71. PubMed ID: 11788096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes.
    Ongagna JC; Sapin R; Pinget M; Belcourt A
    Int J Exp Diabetes Res; 2002; 3(1):1-9. PubMed ID: 11900275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
    Agarwal K; Czaja AJ; Jones DE; Donaldson PT
    Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.
    Nithiyananthan R; Heward JM; Allahabadia A; Franklyn JA; Gough SC
    Thyroid; 2002 Jan; 12(1):3-6. PubMed ID: 11842815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis.
    Barton A; Myerscough A; John S; Gonzalez-Gay M; Ollier W; Worthington J
    Rheumatology (Oxford); 2000 Jan; 39(1):63-6. PubMed ID: 10662875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese.
    Ma Y; Tang X; Chang W; Gao L; Li M; Yan W
    Chin Med J (Engl); 2002 Aug; 115(8):1248-50. PubMed ID: 12515273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CTLA-4 variation with type I diabetes in Filipinos.
    Klitz W; Bugawan TL; Panelo A; Solfelix CM; Buzzetti R; Pozzilli P; Steiner L; Alejandrino M; Erlich HA
    Immunogenetics; 2002 Aug; 54(5):310-3. PubMed ID: 12185534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
    Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
    Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease.
    Vaidya B; Imrie H; Geatch DR; Perros P; Ball SG; Baylis PH; Carr D; Hurel SJ; James RA; Kelly WF; Kemp EH; Young ET; Weetman AP; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):688-91. PubMed ID: 10690877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease.
    Djilali-Saiah I; Schmitz J; Harfouch-Hammoud E; Mougenot JF; Bach JF; Caillat-Zucman S
    Gut; 1998 Aug; 43(2):187-9. PubMed ID: 10189842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis.
    Yanagawa T; Gomi K; Nakao EI; Inada S
    J Rheumatol; 2000 Dec; 27(12):2740-2. PubMed ID: 11128657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults.
    Cosentino A; Gambelunghe G; Tortoioli C; Falorni A
    Ann N Y Acad Sci; 2002 Apr; 958():337-40. PubMed ID: 12021137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.
    Heward JM; Allahabadia A; Carr-Smith J; Daykin J; Cockram CS; Gordon C; Barnett AH; Franklyn JA; Gough SC
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):331-4. PubMed ID: 9861324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.
    Kemp EH; Ajjan RA; Husebye ES; Peterson P; Uibo R; Imrie H; Pearce SH; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):609-13. PubMed ID: 10197076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of CTLA-4 gene for major depression in the Korean population.
    Jun TY; Pae CU; Chae JH; Bahk WM; Kim KS
    Psychiatry Clin Neurosci; 2001 Oct; 55(5):533-7. PubMed ID: 11555351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
    Khankhanian P; Matsushita T; Madireddy L; Lizée A; Din L; Moré JM; Gourraud PA; Hauser SL; Baranzini SE; Oksenberg JR
    BMC Med Genet; 2015 Jul; 16():55. PubMed ID: 26212423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians].
    Andreevskiĭ TV; Sudomoina MA; Gusev EI; Boĭko AN; Alekseenkov AD; Favorova OO
    Mol Biol (Mosk); 2002; 36(4):643-8. PubMed ID: 12173468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders.
    Pavkovic M; Georgievski B; Cevreska L; Spiroski M; Efremov DG
    Am J Hematol; 2003 Feb; 72(2):147-9. PubMed ID: 12555221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo.
    Kemp EH; Ajjan RA; Waterman EA; Gawkrodger DJ; Cork MJ; Watson PF; Weetman AP
    Br J Dermatol; 1999 Jan; 140(1):73-8. PubMed ID: 10215771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.